Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia

Clinical Nutrition

Volumn 33, Issue 5, 2014, Pages 737-748

  Biolo, Gianni ^a   Cederholm, Tommy ^b   Muscaritoli, Maurizio ^c  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UPPSALA UNIVERSITY   (Sweden)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cachexia; Muscle contractile dysfunction; Muscle metabolic dysfunction; Pre cachexia; Sarcopenia; Sarcopenic obesity

Indexed keywords

GLUTAMINE;

ADIPOSE TISSUE; AGED; AGING; BODY COMPOSITION; BODY MASS; CACHEXIA; CHRONIC DISEASE; ENERGY METABOLISM; FEMALE; HUMAN; MALE; MALNUTRITION; METABOLISM; MUSCLE CONTRACTION; NUTRITIONAL STATUS; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; SARCOPENIA; SKELETAL MUSCLE;

ADIPOSE TISSUE; AGED; AGING; BODY COMPOSITION; BODY MASS INDEX; CACHEXIA; CHRONIC DISEASE; ENERGY METABOLISM; FEMALE; GLUTAMINE; HUMANS; MALE; MALNUTRITION; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NUTRITIONAL STATUS; OBESITY; PREVALENCE; SARCOPENIA;

EID: 84906069822     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.03.007     Document Type: Article

References (145)

1. Muscaritoli M., Anker S.D., Argilés J., Aversa Z., Bauer J.M., Biolo G., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010, 29:154-159.
2. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423. European Working Group on Sarcopenia in Older People.
3. Mitch W.E., Goldberg A.L. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. NEngl J Med 1996, 335:1897-1905.
4. Manini T.M., Clark B.C. Dynapenia and aging: an update. JGerontol A Biol Sci Med Sci 2012, 67:28-40.
5. Biolo G., Ciocchi B., Stulle M., Piccoli A., Lorenzon S., Dal Mas V., et al. Metabolic consequences of physical inactivity. JRen Nutr 2005, 15:49-53.
6. Fearon K., Evans W.J., Anker S.D. Myopenia - a new universal term for muscle wasting. JCachexia Sarcopenia Muscle 2011, 2:1-3.
7. Hung W.W., Ross J.S., Boockvar K.S., Siu A.L. Recent trends in chronic disease, impairment and disability among older adults in the United States. BMC Geriatr 2011, 11:47.
8. Miller M.D., Crotty M., Giles L.C., Bannerman E., Whitehead C., Cobiac L., et al. Corrected arm muscle area: an independent predictor of long-term mortality in community-dwelling older adults?. JAm Geriatr Soc 2002, 50:1272-1277.
9. Vermeeren M.A., Creutzberg E.C., Schols A.M., Postma D.S., Pieters W.R., Roldaan A.C., et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006, 100:1349-1355. COSMIC Study Group.
10. Mourtzakis M., Prado C.M., Lieffers J.R., Reiman T., McCargar L.J., Baracos V.E. Apractical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008, 33:997-1006.
11. Fearon K., Strasser F., Anker S.D., Bosaeus I., Bruera E., Fainsinger R.L., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011, 12:489-495.
12. Coin A., Giannini S., Minicuci N., Rinaldi G., Pedrazzoni M., Minisola S., et al. Limb fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old Italian population. Clin Nutr 2012, 31:506-511.
13. Norman K., Stobäus N., Pirlich M., Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis - clinical relevance and applicability of impedance parameters. Clin Nutr 2012, 31:854-861.
14. Martin L., Birdsell L., Macdonald N., Reiman T., Clandinin M.T., McCargar L.J., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. JClin Oncol 2013, 31:1539-1547.
15. Mijnarends D.M., Meijers J.M., Halfens R.J., Ter Borg S., Luiking Y.C., Verlaan S., et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. JAm Med Dir Assoc 2013, 14:170-178.
16. Malmstrom T.K., Morley J.E. Sarcopenia: the target population. JFrailty Aging 2013, 2:55-56.
17. Malmstrom T.K., Morley J.E. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. JAm Med Dir Assoc 2013, 14:531-532.
18. Volpato S., Bianchi L., Cherubini A., Landi F., Maggio M., Savino E., et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. JGerontol A Biol Sci Med Sci 2013, 69:438-446.
19. Biolo G., Guadagni M., Ciocchi B. Does cachexia prevention improve outcome of chronic disease and cancer?. Intern Emerg Med 2011, 6:101-103.
20. Raslan M., Gonzalez M.C., Torrinhas R.S., Ravacci G.R., Pereira J.C., Waitzberg D.L. Complementarity of Subjective Global Assessment (SGA) and Nutritional Risk Screening 2002 (NRS 2002) for predicting poor clinical outcomes in hospitalized patients. Clin Nutr 2011, 30:49-53.
21. Cereda E., Lucchin L., Pedrolli C., D'Amicis A., Gentile M.G., Battistini N.C., et al. Nutritional care routines in Italy: results from the PIMAI (Project: Iatrogenic MAlnutrition in Italy) study. Eur J Clin Nutr 2010, 64:894-898.
22. Vadan R., Gheorghe L.S., Constantinescu A., Gheorghe C. The prevalence of malnutrition and the evolution of nutritional status in patients with moderate to severe forms of Crohn's disease treated with Infliximab. Clin Nutr 2011, 30:86-91.
23. Caporali R., Caccialanza R., Bonino C., Klersy C., Cereda E., Xoxi B., et al. Disease-related malnutrition in outpatients with systemic sclerosis. Clin Nutr 2012, 31:666-671.
24. Baracos V.E., Reiman T., Mourtzakis M., Gioulbasanis I., Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010, 91:1133S-1137S.
25. Wagner D., Adunka C., Kniepeiss D., Jakoby E., Schaffellner S., Kandlbauer M., et al. Serum albumin, subjective global assessment, body mass index and the bioimpedance analysis in the assessment of malnutrition in patients up to 15 years after liver transplantation. Clin Transplant 2011, 25:E396-E400.
26. Montano-Loza A.J., Meza-Junco J., Prado C.M., Lieffers J.R., Baracos V.E., Bain V.G., et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012, 10:166-173.
27. Fülster S., Tacke M., Sandek A., Ebner N., Tschöpe C., Doehner W., et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 2013, 34:512-519.
28. Christensen H.M., Kistorp C., Schou M., Keller N., Zerahn B., Frystyk J., et al. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status. Endocrine 2013, 43:626-634.
29. van Bokhorst-de van der Schueren M.A., Konijn N.P., Bultink I.E., Lems W.F., Earthman C.P., van Tuyl L.H. Relevance of the new pre-cachexia and cachexia definitions for patients with rheumatoid arthritis. Clin Nutr 2012, 31:1008-1010.
30. Vandewoude M.F., Alish C.J., Sauer A.C., Hegazi R.A. Malnutrition-sarcopenia syndrome: is this the future of nutrition screening and assessment for older adults?. JAging Res 2012, [Published online Sep 13]. 10.1155/2012/651570.
31. Tandon P., Ney M., Irwin I., Ma M.M., Gramlich L., Bain V.G., et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 2012, 18:1209-1216.
32. Guarnieri G., Antonione R., Biolo G. Mechanisms of malnutrition in uremia. JRen Nutr 2003, 13:153-157.
33. Pupim L.B., Heimbürger O., Qureshi A.R., Ikizler T.A., Stenvinkel P. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int 2005, 68:2368-2374.
34. Kim T.N., Park M.S., Yang S.J., Yoo H.J., Kang H.J., Song W., et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010, 33:1497-1499.
35. Pedersen B.K. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun 2011, 25:811-816.
36. Aversa Z., Bonetto A., Penna F., Costelli P., Di Rienzo G., Lacitignola A., et al. Changes in myostatin signaling in non-weight-losing cancer patients. Ann Surg Oncol 2012, 19:1350-1356.
37. Bonetto A., Penna F., Aversa Z., Mercantini P., Baccino F.M., Costelli P., et al. Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patients. Muscle Nerve 2013, 48:387-392.
38. Demontis F., Piccirillo R., Goldberg A.L., Perrimon N. The influence of skeletal muscle on systemic aging and lifespan. Aging Cell 2013, 12:943-949.
39. Ji L., Meng H., Dong B. Factors associated with poor nutritional status among the oldest-old. Clin Nutr 2012, 31:922-926.
40. Genton L., Karsegard V.L., Chevalley T., Kossovsky M.P., Darmon P., Pichard C. Body composition changes over 9 years in healthy elderly subjects and impact of physical activity. Clin Nutr 2011, 30:436-442.
41. Pasiakos S.M., Vislocky L.M., Carbone J.W., Altieri N., Konopelski K., Freake H.C., et al. Acute energy deprivation affects skeletal muscle protein synthesis and associated intracellular signaling proteins in physically active adults. JNutr 2010, 140:745-751.
42. Biolo G., Ciocchi B., Stulle M., Bosutti A., Barazzoni R., Zanetti M., et al. Calorie restriction accelerates the catabolism of lean body mass during 2wk of bed rest. Am J Clin Nutr 2007, 86:366-372.
43. Seelaender M., Batista M., Lira F., Silverio R., Rossi-Fanelli F. Inflammation in cancer cachexia: to resolve or not to resolve (is that the question?). Clin Nutr 2012, 31:562-566.
44. de Boer M.D., Seynnes O.R., di Prampero P.E., Pisot R., Mekjavić I.B., Biolo G., et al. Effect of 5 weeks horizontal bed rest on human muscle thickness and architecture of weight bearing and non-weight bearing muscles. Eur J Appl Physiol 2008, 104:401-407.
45. Brocca L., Cannavino J., Coletto L., Biolo G., Sandri M., Bottinelli R., et al. The time course of the adaptations of human muscle proteome to bed rest and the underlying mechanisms. JPhysiol 2012, 590:5211-5230.
46. Ferrando A.A., Stuart C.A., Sheffield-Moore M., Wolfe R.R. Inactivity amplifies the catabolic response of skeletal muscle to cortisol. JClin Endocrinol Metab 1999, 84:3515-3521.
47. Engels P.T., Beckett A.N., Rubenfeld G.D., Kreder H., Finkelstein J.A., da Costa L., et al. Physical rehabilitation of the critically ill trauma patient in the ICU. Crit Care Med 2013, 41:1790-1801.
48. Crocker T., Forster A., Young J., Brown L., Ozer S., Smith J., et al. Physical rehabilitation for older people in long-term care. Cochrane Database Syst Rev 2013, 2:CD004294.
49. Cramp F., Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012, 11:CD006145.
50. Zainuldin R., Mackey M.G., Alison J.A. Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011, 10:CD003236.
51. Müller M.J., Wang Z., Heymsfield S.B., Schautz B., Bosy-Westphal A. Advances in the understanding of specific metabolic rates of major organs and tissues in humans. Curr Opin Clin Nutr Metab Care 2013, 16:501-508.
52. Blanc S., Normand S., Ritz P., Pachiaudi C., Vico L., Gharib C., et al. Energy and water metabolism, body composition, and hormonal changes induced by 42 days of enforced inactivity and simulated weightlessness. JClin Endocrinol Metab 1998, 83:4289-4297.
53. Ritz P., Acheson K.J., Gachon P., Vico L., Bernard J.J., Alexandre C., et al. Energy and substrate metabolism during a 42-day bed-rest in a head-down tilt position in humans. Eur J Appl Physiol Occup Physiol 1998, 78:308-314.
54. Shimizu-Fujiwara M., Komaki H., Nakagawa E., Mori-Yoshimura M., Oya Y., Fujisaki T., et al. Decreased resting energy expenditure in patients with Duchenne muscular dystrophy. Brain Dev 2012, 34:206-212.
55. Langius J.A., Kruizenga H.M., Uitdehaag B.M., Langendijk J.A., Doornaert P., Leemans C.R., et al. Resting energy expenditure in head and neck cancer patients before and during radiotherapy. Clin Nutr 2012, 31:549-554.
56. Olsen R.H., Krogh-Madsen R., Thomsen C., Booth F.W., Pedersen B.K. Metabolic responses to reduced daily steps in healthy nonexercising men. JAm Med Assoc 2008, 299:1261-1263.
57. Bosutti A., Malaponte G., Zanetti M., Castellino P., Heer M., Guarnieri G., et al. Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. JClin Endocrinol Metab 2008, 93:3226-3229.
58. Biolo G., Agostini F., Simunic B., Sturma M., Torelli L., Preiser J.C., et al. Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5wk of bed rest. Am J Clin Nutr 2008, 88:950-958.
59. Guillet C., Masgrau A., Walrand S., Boirie Y. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Obes Rev 2012, 13(Suppl.2):51-57.
60. Masgrau A., Mishellany-Dutour A., Murakami H., Beaufrère A.M., Walrand S., Giraudet C., et al. Time-course changes of muscle protein synthesis associated with obesity-induced lipotoxicity. JPhysiol 2012, 590:5199-5210.
61. Guillet C., Delcourt I., Rance M., Giraudet C., Walrand S., Bedu M., et al. Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. JClin Endocrinol Metab 2009, 94:3044-3050.
62. Manini T.M. Energy expenditure and aging. Ageing Res Rev 2010, 9:1-11.
63. Bouteloup C., Desport J.C., Clavelou P., Guy N., Derumeaux-Burel H., Ferrier A., et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. JNeurol 2009, 256:1236-1242.
64. Genton L., Viatte V., Janssens J.P., Héritier A.C., Pichard C. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clin Nutr 2011, 30:553-559.
65. Müller M.J., Böttcher J., Selberg O., Weselmann S., Böker K.H., Schwarze M., et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 1999, 69:1194-1201.
66. Sergi G., Coin A., Marin S., Vianello A., Manzan A., Peruzza S., et al. Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease. Respir Med 2006, 100:1918-1924.
67. Mitchell W.K., Williams J., Atherton P., Larvin M., Lund J., Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 2012, 3:260. 10.3389/fphys.2012.00260.
68. Norman K., Stobäus N., Reiß J., Schulzke J., Valentini L., Pirlich M. Effect of sexual dimorphism on muscle strength in cachexia. JCachexia Sarcopenia Muscle 2012, 3:111-116.
69. Binkley N., Krueger D., Buehring B. What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?". Osteoporos Int 2013, 24:2955-2959.
70. Rittweger J., Simunic B., Bilancio G., De Santo N.G., Cirillo M., Biolo G., et al. Bone loss in the lower leg during 35 days of bed rest is predominantly from the cortical compartment. Bone 2009, 44:612-618.
71. Biolo G., Heer M., Narici M., Strollo F. Microgravity as a model of ageing. Curr Opin Clin Nutr Metab Care 2003, 6:31-40.
72. Cianferotti L., Brandi M.L. Muscle-bone interactions: basic and clinical aspects. Endocrine 2014, 45:165-177.
73. Braun T., Schett G. Pathways for bone loss in inflammatory disease. Curr Osteoporos Rep 2012, 10:101-108.
74. Chen Y.H., Wu Y.W., Yang W.S., Wang S.S., Lee C.M., Chou N.K., et al. Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. PLoS One 2012, 7(8):e44242. 10.1371/journal.pone.0044242.
75. Zhou J., Zhang Q., Yuan X., Wang J., Li C., Sheng H., et al. Association between metabolic syndrome and osteoporosis: a meta-analysis. Bone 2013, 57:30-35.
76. Romme E.A., Smeenk F.W., Rutten E.P., Wouters E.F. Osteoporosis in chronic obstructive pulmonary disease. Expert Rev Respir Med 2013, 7:397-410.
77. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
78. Srikanthan P., Karlamangla A.S. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. JClin Endocrinol Metab 2011, 96:2898-2903.
79. Hamburg N.M., McMackin C.J., Huang A.L., Shenouda S.M., Widlansky M.E., Schulz E., et al. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol 2007 Dec, 27(12):2650-2656. [Epub 2007 Oct 11].
80. Mazzucco S., Agostini F., Mangogna A., Cattin L., Biolo G. Prolonged inactivity up-regulates cholesteryl ester transfer protein independently of body fat changes in humans. JClin Endocrinol Metab 2010, 95:2508-2512.
81. Tessari P., Cecchet D., Cosma A., Puricelli L., Millioni R., Vedovato M., et al. Insulin resistance of amino acid and protein metabolism in type 2 diabetes. Clin Nutr 2011, 30:267-272.
82. Biolo G., Ciocchi B., Lebenstedt M., Barazzoni R., Zanetti M., Platen P., et al. Short-term bed rest impairs amino acid-induced protein anabolism in humans. JPhysiol 2004, 558:381-388.
83. Biolo G. Protein metabolism and requirements. World Rev Nutr Diet 2013, 105:12-20.
84. Bauer J., Biolo G., Cederholm T., Cesari M., Cruz-Jentoft A.J., Morley J.E., et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. JAm Med Dir Assoc 2013, 14:542-559.
85. Hartl W.H., Alpers D.H. The trophic effects of substrate, insulin, and the route of administration on protein synthesis and the preservation of small bowel mucosal mass in large mammals. Clin Nutr 2011, 30:20-27.
86. Biolo G., De Cicco M., Lorenzon S., Dal Mas V., Fantin D., Paroni R., et al. Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery. Crit Care Med 2008, 36:1768-1775.
87. Biolo G., Zorat F., Antonione R., Ciocchi B. Muscle glutamine depletion in the intensive care unit. Int J Biochem Cell Biol 2005, 37:2169-2179.
88. Agostini F., Heer M., Guarnieri G., Biolo G. Physical inactivity decreases whole body glutamine turnover independently from changes in proteolysis. JPhysiol 2008, 586:4775-4781.
89. Biolo G., Antonione R., De Cicco M. Glutathione metabolism in sepsis. Crit Care Med 2007, 35:S591-S595.
90. Bonetto A., Penna F., Muscaritoli M., Minero V.G., Rossi Fanelli F., Baccino F.M., et al. Are antioxidants useful for treating skeletal muscle atrophy?. Free Radic Biol Med 2009, 47:906-916.
91. Agostini F., Dalla Libera L., Rittweger J., Mazzucco S., Jurdana M., Mekjavic I.B., et al. Effects of inactivity on human muscle glutathione synthesis by a double-tracer and single-biopsy approach. JPhysiol 2010, 588:5089-5104.
92. Arnold A.S., Egger A., Handschin C. PGC-1α and myokines in the aging muscle - a mini-review. Gerontology 2011, 57:37-43.
93. Drummond M.J., Timmerman K.L., Markofski M.M., Walker D.K., Dickinson J.M., Jamaluddin M., et al. Short-term bed rest increases TLR4 and IL-6 expression in skeletal muscle of older adults. Am J Physiol Regul Integr Comp Physiol 2013, 305:R216-R223.
94. Washington T.A., White J.P., Davis J.M., Wilson L.B., Lowe L.L., Sato S., et al. Skeletal muscle mass recovery from atrophy in IL-6 knockout mice. Acta Physiol (Oxf) 2011, 202:657-669.
95. Welc S.S., Clanton T.L., Dineen S.M., Leon L.R. Heat stroke activates a stress-induced cytokine response in skeletal muscle. JAppl Physiol 2013, 115:1126-1137.
96. Hofmann T., Elbelt U., Stengel A. Irisin as a muscle-derived hormone stimulating thermogenesis - a critical update. Peptides 2014, 54C:89-100.
97. Hee Park K., Zaichenko L., Brinkoetter M., Thakkar B., Sahin-Efe A., Joung K.E., et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. JClin Endocrinol Metab 2013, 98:4899-4907.
98. Merli M., Giusto M., Lucidi C., Giannelli V., Pentassuglio I., Di Gregorio V., et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis 2013, 28:281-284.
99. Martín-González C., González-Reimers E., Santolaria-Fernández F., Fernández-Rodríguez C., García-Valdecasas-Campelo E., González Díaz A., et al. Prognostic value of changes in lean and fat mass in alcoholics. Clin Nutr 2011, 30:822-830.
100. Huang J.W., Lien Y.C., Wu H.Y., Yen C.J., Pan C.C., Hung T.W., et al. Lean body mass predicts long-term survival in Chinese patients on peritoneal dialysis. PLoS One 2013, 8(1):e54976.
101. Schols A.M., Broekhuizen R., Weling-Scheepers C.A., Wouters E.F. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82:53-59.
102. Vestbo J., Prescott E., Almdal T., Dahl M., Nordestgaard B.G., Andersen T., et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006, 173:79-83.
103. Verhage T.L., Heijdra Y., Molema J., Vercoulen J., Dekhuijzen R. Associations of muscle depletion with health status. Another gender difference in COPD?. Clin Nutr 2011, 30:332-338.
104. Muscaritoli M., Molfino A., Rossi Fanelli F. Muscle depletion and the prediction of chemotherapy toxicity. Intern Emerg Med 2013, 8:373-375.
105. Prado C.M., Baracos V.E., McCargar L.J., Reiman T., Mourtzakis M., Tonkin K., et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009, 15:2920-2926.
106. Peng P., Hyder O., Firoozmand A., Kneuertz P., Schulick R.D., Huang D., et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. JGastrointest Surg 2012, 16:1478-1486.
107. Sheetz K.H., Zhao L., Holcombe S.A., Wang S.C., Reddy R.M., Lin J., et al. Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer. Dis Esophagus 2013, 26:716-722.
108. Han S.S., Kim K.W., Kim K.I., Na K.Y., Chae D.W., Kim S., et al. Lean mass index: a better predictor of mortality than body mass index in elderly Asians. JAm Geriatr Soc 2010, 58:312-317.
109. Landi F., Liperoti R., Fusco D., Mastropaolo S., Quattrociocchi D., Proia A., et al. Sarcopenia and mortality among older nursing home residents. JAm Med Dir Assoc 2012, 13:121-126.
110. Landi F., Liperoti R., Russo A., Giovannini S., Tosato M., Capoluongo E., et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012, 31:652-658.
111. Roshanravan B., Robinson-Cohen C., Patel K.V., Ayers E., Littman A.J., de Boer I.H., et al. Association between physical performance and all-cause mortality in CKD. JAm Soc Nephrol 2013, 24:822-830.
112. Artero E.G., Lee D.C., Lavie C.J., España-Romero V., Sui X., Church T.S., et al. Effects of muscular strength on cardiovascular risk factors and prognosis. JCardiopulm Rehabil Prev 2012, 32:351-358.
113. Colín-Ramírez E., Orea-Tejeda A., Castillo-Martínez L., Montaño-Hernández P., Sánchez-Ramírez A., Pineda-Juárez J.A., et al. Malnutrition syndrome, but not body mass index, is associated to worse prognosis in heart failure patients. Clin Nutr 2011, 30:753-758.
114. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62:115-120.
115. Dronkers J.J., Chorus A.M., van Meeteren N.L., Hopman-Rock M. The association of pre-operative physical fitness and physical activity with outcome after scheduled major abdominal surgery. Anaesthesia 2013, 68:67-73.
116. Takata Y., Shimada M., Ansai T., Yoshitake Y., Nishimuta M., Nakagawa N., et al. Physical performance and 10-year mortality in a 70-year-old community-dwelling population. Aging Clin Exp Res 2012, 24:257-264.
117. Chen P.J., Lin M.H., Peng L.N., Liu C.L., Chang C.W., Lin Y.T., et al. Predicting cause-specific mortality of older men living in the Veterans home by handgrip strength and walking speed: a 3-year, prospective cohort study in Taiwan. JAm Med Dir Assoc 2012, 13:517-521.
118. Merli M., Giusto M., Molfino A., Bonetto A., Rossi M., Ginanni Corradini S., et al. MuRF-1 and p-GSK3β expression in muscle atrophy of cirrhosis. Liver Int 2013, 33:714-721.
119. Hong H.C., Hwang S.Y., Choi H.Y., Yoo H.J., Seo J.A., Kim S.G., et al. The relationship between sarcopenia and non-alcoholic fatty liver disease: the Korean sarcopenic obesity study. Hepatology 2013, 10.1002/hep.26716.
120. Muscaritoli M., Lucia S., Molfino A. Sarcopenia in critically ill patients: the new pandemia. Minerva Anestesiol 2013, 79:771-777.
121. Meijers J.M., Halfens R.J., Wilson L., Schols J.M. Estimating the costs associated with malnutrition in Dutch nursing homes. Clin Nutr 2012, 31:65-68.
122. Lim S.L., Ong K.C., Chan Y.H., Loke W.C., Ferguson M., Daniels L. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clin Nutr 2012, 31:345-350.
123. Muscaritoli M., Lucia S., Molfino A., Cederholm T., Rossi Fanelli F. Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?. Intern Emerg Med 2013, 8:553-560.
124. Evans W.J., Morley J.E., Argilés J., Bales C., Baracos V., Guttridge D., et al. Cachexia: a new definition. Clin Nutr 2008, 27:793-799.
125. Muscaritoli M., Molfino A., Gioia G., Laviano A., Rossi Fanelli F. The "parallel pathway": a novel nutritional and metabolic approach to cancer patients. Intern Emerg Med 2011, 6:105-112.
126. Awad S., Tan B.H., Cui H., Bhalla A., Fearon K.C., Parsons S.L., et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 2012, 31:74-77.
127. Fearon K.C. The 2011 ESPEN Arvid Wretlind lecture: cancer cachexia: the potential impact of translational research on patient-focused outcomes. Clin Nutr 2012, 31:577-582.
128. Slaughter S.E., Eliasziw M., Morgan D., Drummond N. Incidence and predictors of eating disability among nursing home residents with middle-stage dementia. Clin Nutr 2011, 30:172-177.
129. Roubenoff R., Roubenoff R.A., Cannon J.G., Kehayias J.J., Zhuang H., Dawson-Hughes B., et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. JClin Invest 1994, 93:2379-2386.
130. Freedman R.J., Aziz N., Albanes D., Hartman T., Danforth D., Hill S., et al. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. JClin Endocrinol Metab 2004, 89:2248-2253.
131. Muscaritoli M., Molfino A., Bollea M.R., Rossi Fanelli F. Malnutrition and wasting in renal disease. Curr Opin Clin Nutr Metab Care 2009, 12:378-383.
132. Prado C.M., Wells J.C., Smith S.R., Stephan B.C., Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 2012, 31:583-601.
133. Prado C.M., Lieffers J.R., McCargar L.J., Reiman T., Sawyer M.B., Martin L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9:629-635.
134. Del Fabbro E., Parsons H., Warneke C.L., Pulivarthi K., Litton J.K., Dev R., et al. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist 2012, 17:1240-1245.
135. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005, 81:543-554.
136. Kapoor J.R., Heidenreich P.A. Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J 2010, 159:75-80.
137. Akinnusi M.E., Pineda L.A., El Solh A.A. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 2008, 36:151-158.
138. Cao C., Wang R., Wang J., Bunjhoo H., Xu Y., Xiong W. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One 2012, 7(8):e43892. 10.1371/journal.pone.0043892.
139. Morse W.I., Soeldner J.S. The non-adipose body mass of obese women: evidence of increased muscularity. Can Med Assoc J 1964, 90:723-725.
140. Kalantar-Zadeh K., Streja E., Kovesdy C.P., Oreopoulos A., Noori N., Jing J., et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010, 85:991-1001.
141. Kalantar-Zadeh K., Streja E., Molnar M.Z., Lukowsky L.R., Krishnan M., Kovesdy C.P., et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol 2012, 175:793-803.
142. Casas-Vara A., Santolaria F., Fernández-Bereciartúa A., González-Reimers E., García-Ochoa A., Martínez-Riera A. The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition 2012, 28:616-622.
143. Guadagni M., Biolo G. Effects of inflammation and/or inactivity on the need for dietary protein. Curr Opin Clin Nutr Metab Care 2009, 12:617-622.
144. Zeanandin G., Molato O., Le Duff F., Guérin O., Hébuterne X., Schneider S.M. Impact of restrictive diets on the risk of undernutrition in a free-living elderly population. Clin Nutr 2012, 31:69-73.
145. Thibault R., Genton L., Pichard C. Body composition: why, when and for who?. Clin Nutr 2012, 31:435-447.